Annals of Oncology

News:

Development of temozolomide and problems with publicity
Ann Oncol 4: 178.
[PDF] [Request Permissions]

Mertelsmann to carry out first gene trial in Europe
Ann Oncol 4: 178-179.
[PDF] [Request Permissions]

Battle between army and NCI over breast cancer money
Ann Oncol 4: 179.
[PDF] [Request Permissions]

Clinton to slash price of taxol?
Ann Oncol 4: 179-180.
[PDF] [Request Permissions]

UICC to hold Pierre Denoix Memorial Lecture
Ann Oncol 4: 180.
[PDF] [Request Permissions]

Editorials:

Bertrand Coiffier

Interferon alpha-recombinant in the treatment of follicular lymphoma patients
Ann Oncol 4: 182-183.
[PDF] [Request Permissions]

Richard Camplejohn

A role for proliferative measurements in clinical oncology?
Ann Oncol 4: 184-185.
[PDF] [Request Permissions]

Review:

Leonardo Santi

Book review
Ann Oncol 4: 186.
[PDF] [Request Permissions]

F. De Conno, C. Ripamonti, A. Sbanotto, L. Saita, E. Zecca, and V. Ventafridda

The pharmacological management of cancer pain: Part 1: The role of non opioid and adjuvant drugs
Ann Oncol 4: 187-193.
[PDF] [Request Permissions]

Commentary:

T. Ojasoo, M. E. Lippman, H. Rochefort, and M. Namer

Breast cancer: When tumor markers become targets for drugs
Ann Oncol 4: 195-197.
[PDF] [Request Permissions]

Arena:

E. Tomiak and M. Piccart

Routine follow-up of patients after primary therapy for early breast cancer: Changing concepts and challenges for the future
Ann Oncol 4: 199-204.
[Abstract] [PDF] [Request Permissions]

Original articles:

P. McLaughlin, F. Cabanillas, F. B. Hagemeister, F. Swan, Jr., J. E. Romaguera, S. Taylor, M. A. Rodriguez, W. S. Velasquez, J. R. Redman, and J. U. Gutterman

CHOP-Bleo plus interferon for stage IV low-grade lymphoma
Ann Oncol 4: 205-211.
[Abstract] [PDF] [Request Permissions]

R. Silvestrini, M. G. Daidone, G. Del Bino, M. Mastore, A. Luisi, G. Di Fronzo, and P. Boracchi

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers
Ann Oncol 4: 213-219.
[Abstract] [PDF] [Request Permissions]

S. Kim, S. B. Howell, E. McClay, S. Kirmani, R. Goel, S. Plaxe, P. Braly, and A. Bonetti

Dose intensification of cisplatin chemotherapy through biweekly administration
Ann Oncol 4: 221-227.
[Abstract] [PDF] [Request Permissions]

A. Gruber, H. Norder, L. Magnius, M. Rotzén, C. Rubio, L. Grillner, and M. Björkholm

Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders
Ann Oncol 4: 229-234.
[Abstract] [PDF] [Request Permissions]

B. Glimelius

Biochemical modulation of 5-fluorouracil: A randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer
Ann Oncol 4: 235-240.
[Abstract] [PDF] [Request Permissions]

M. G. Arena, C. N. Sternberg, M. Zeuli, P. De Carli, A. Cancrini, V. Pansadoro, and F. Calabresi

Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer
Ann Oncol 4: 241-244.
[Abstract] [PDF] [Request Permissions]

L. Lombardo, D. Rota Scalabrini, P. Vineis, and M. De La Pierre

Malignant lymphoproliferative disorders in liver cirrhosis
Ann Oncol 4: 245-250.
[Abstract] [PDF] [Request Permissions]

Book reviews:

Jean-Pierre Mach

Book review
Ann Oncol 4: 219.
[PDF] [Request Permissions]

V. Craig Jordan

Book review
Ann Oncol 4: 227-228.
[PDF] [Request Permissions]

Short reports:

R. Buzzoni, M. Colleoni, E. Bajetta, F. Nolè, P. Nelli, C. A. De Palma, and F. de Braud

Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma
Ann Oncol 4: 251-253.
[Abstract] [PDF] [Request Permissions]

S. Verma, I. C. Quirt, E. A. Eisenhauer, N. A. Iscoe, V. J. Young, A. J. Bodurtha, and J. Davidson

A phase II study of weekly Edatrexate (10-EDAM) in metastatic melanoma: A National Cancer Institute of Canada Clinical Trials Group Study
Ann Oncol 4: 254-255.
[Abstract] [PDF] [Request Permissions]

Letters:

D. Pectasides, P. Arapantoni-Dadiotou, D. Louloudaki, I. Varthalitis, M. Dimitriades, and A. Athanassiou

Gastric adenocarcinoma after gastric lymphoma: The role of chemoradiotherapy
Ann Oncol 4: 256-257.
[PDF] [Request Permissions]

J. Fisken, R. C. F. Leonard, and J. E. Roulston

Should we regard CA125 as the indication to treat relapsing ovarian cancer?
Ann Oncol 4: 257.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.